Back HIV/AIDS HIV/AIDS Topics HIV Treatment

CROI 2014: Retrovirus Conference Now Underway in Boston

The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) kicked off in Boston this week with a program for young investigators, a press conference on new hepatitis C treatments, and opening lectures on HIV immune response and cross-species transmission and an update on the epidemic in West Africa.

HIVandHepatitis.com will be on site all week bringing you the latest news.alt

Read more:

CROI 2014: The Role of Interferon in HIV Response [VIDEO]

Although interferon is on its way out as a standard of care for hepatitis C, researchers are learning more about its role in HIV, conference vice chair Julie Overbaugh said at a media briefing on the opening day of the 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) this week in Boston.

alt

Read more:

Vacc-4x Therapeutic Vaccine May Lower HIV Viral Load Set-point

An experimental therapeutic vaccine did not slow CD4 T-cell decline or enable study participants to safely interrupt antiretroviral therapy (ART) longer, but it did appear to leave HIV viral load at lower levels, researchers reported in the February 11 advance edition of Lancet Infectious Diseases.

alt

Read more:

CROI 2014: Retrovirus Conference Starts Monday in Boston

The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) will take place next week, March 3-6, at the Hynes Convention Center in Boston. HIVandHepatitis.com will be on site all week to bring you the latest news coverage about HIV, hepatitis C, and related topics.

alt

Read more:

Studies Reveal Age, Race, and Sex Disparities in HIV Care and Outcomes

Women, African-Americans, and people who inject drugs are on average less likely to remain in care,start antiretroviral therapy (ART), or achieve viral load suppression, while young people are more likely to seek HIV care later in the course of their disease, according to 2 recently published studies.

alt

Read more:

Low CD4 Count Despite Viral Suppression Linked to Higher Risk of Death

HIV positive people who have poor CD4 T-cell recovery on antiretroviral therapy (ART) had higher mortality than those with good immunological response, even if they reached undetectable viral load, according to a study published in the January 22 advance edition of Clinical Infectious Diseases.

alt

Read more:

Updated Guidelines for Antiretroviral Treatment of Children with HIV

The Department of Health and Human Services this week updated its Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Changes to the children's guidelines include specific drug recommendations and information about a possible cure of an HIV-infected infant following very early treatment.

alt

Read more: